Benzinga Rankings give you vital metrics on any stock – anytime.
Explore iShares Trust iShares Neuroscience and Healthcare ETF stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for IBRN.
Open | $21.25 |
High | $21.25 |
52 Wk High | $28.74 |
AUM | 3.40M |
Dividend | $0.11 |
Ex-Div Date | Dec 17, 2024 |
Volume | 1.29K |
Market Cap | $5.10B |
Mgmt Fee | 0.47% |
P/E Ratio | 20.00 |
Prev. Close | $21.24 |
Low | $21.14 |
52 Wk Low | $17.86 |
Shares Out | 150.00K |
Yield | 0.51% |
Div. Freq | S |
Avg. Volume Daily | 962.00 |
Beta | 0.77 |
Avg. Expense Ratio | 0.47% |
P/B Ratio | 3.11 |
You can purchase shares of iShares Trust iShares Neuroscience and Healthcare ETF (ARCA:IBRN) through any online brokerage.
There are no as such competitors for iShares Trust iShares Neuroscience and Healthcare ETF.
There is no analysis for iShares Trust iShares Neuroscience and Healthcare ETF to provide a consensus price target.
The stock price for iShares Trust iShares Neuroscience and Healthcare ETF (ARCA: IBRN) is $21.1369 last updated May 7, 2025 at 8:00 PM EDT.
There are no upcoming dividends for iShares Trust iShares Neuroscience and Healthcare ETF.
iShares Trust iShares Neuroscience and Healthcare ETF does not have any upcoming earnings scheduled.
There is no upcoming split for iShares Trust iShares Neuroscience and Healthcare ETF.
Open | $21.25 |
High | $21.25 |
52 Wk High | $28.74 |
AUM | 3.40M |
Dividend | $0.11 |
Ex-Div Date | Dec 17, 2024 |
Volume | 1.29K |
Market Cap | $5.10B |
Mgmt Fee | 0.47% |
P/E Ratio | 20.00 |
Prev. Close | $21.24 |
Low | $21.14 |
52 Wk Low | $17.86 |
Shares Out | 150.00K |
Yield | 0.51% |
Div. Freq | S |
Avg. Volume Daily | 962.00 |
Beta | 0.77 |
Avg. Expense Ratio | 0.47% |
P/B Ratio | 3.11 |
Sector | Healthcare |
Category | Mid Performer-Mid Growth |
Investment Style | Large Cap Blend |
Fund Inception | Aug 24, 2022 |
Managers | Paul Whitehead Jennifer Hsui Greg Savage |
Definition | Most of the stocks in this equity fund have average financial performance and average growth potential |
Symbol | Name | Share % |
---|---|---|
DYN | Dyne Therapeutics Inc | 5.00% |
AS | Argenx Se Ads | 4.36% |
ACAD | Acadia Pharmaceuticals... | 4.14% |
BHVN | Biohaven Pharmaceutica... | 4.22% |
SRPT | Sarepta Therapeutics I... | 4.16% |
ITCI | Intra-Cellular Therapi... | 4.40% |
XENE | Xenon Pharmaceuticals ... | 4.03% |
IE | Alkermes Plc | 4.18% |
CERE | Cerevel Therapeutics H... | 4.05% |
NBIX | Neurocrine Biosciences... | 4.29% |
PTCT | Ptc Therapeutics Inc | 4.24% |
KR | Sk Biopharmaceuticals ... | 3.97% |
CPRX | Carver Bancorp Inc. | 4.83% |
SRRK | Scholar Rock Holding C... | 3.82% |
BIIB | Biogen Inc | 3.96% |
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.